3D Systems Class Action Lawsuit Claims Investor Deception [2025]

The legal challenges for 3D Systems go beyond investor lawsuits. The company settled with three U.S. government departments for $27 million. The company’s troubles deepened when it filed a form with the SEC to delay its annual report in March 2021, causing the stock price to fall by $7.62 per share – almost 20% of its value. This piece will get into how these financial disclosures have sparked multiple legal challenges and what it all means for current and potential investors.

Please see the various investor resources below for an additional wealth of information.

Lead Plaintiff Deadlines

Investor Resources

Frequently Asked Questions

Shareholder Rights

Timeline of Events

Report a Fraud

3D Systems faces class action over alleged investor deception

Investors have filed a major class action lawsuit against 3D Systems Corporation (NYSE: DDD). The lawsuit covers those who bought securities between August 13, 2024, and May 12, 2025. The legal action targets the company and its top executives in the United States District Court for the District of Delaware. President and CEO Jeffrey A. Graves and CFO Jeffrey D. Creech are named as defendants.

The lawsuit claims violations of federal securities laws under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5. The plaintiffs assert that 3D Systems and its executives made false and misleading statements about their business conditions during this period.

The complaint points out that 3D Systems downplayed how reduced customer spending affected their operations. The company also overstated its ability to handle tough industry conditions. The lawsuit also claims they failed to reveal that changes to milestone criteria in their United Therapeutics Corporation partnership would hurt the Regenerative Medicine Program revenue.

The company’s problems came to light on March 26, 2025, when they released their fourth quarter and full-year 2024 financial results. They reported a USD 9.00 million revenue reduction due to changed accounting estimates for the Regenerative Medicine program. The stock price dropped by nearly 21% as a result.

Things got worse on May 12, 2025. 3D Systems announced poor first quarter 2025 results with revenue of USD 94.50 million. This marked an 8% drop year-over-year and missed analyst expectations of USD 99.50 million. They also pulled their full-year 2025 outlook, blaming ongoing weak customer spending and economic uncertainty. The next day, the stock price fell another 26.6%.

Under the Private Securities Litigation Reform Act of 1995, any investor who bought 3D Systems securities during this period can apply to become lead plaintiff. The deadline is set for August 12, 2025.

Plaintiffs cite financial disclosures that triggered stock decline

The 3D Systems Class Action Lawsuit centers around financial disclosures that show a pattern of missed targets and market responses. The company’s fourth quarter 2024 results in March 2025 showed non-GAAP earnings per share of -USD 0.19, which missed analyst estimates by USD 0.08 per share. The quarterly revenue came in at USD 111.00 million, showing a 3.4% drop from the previous year and falling USD 4.17 million short of analyst expectations.

The company reduced its Q4 revenue by USD 9.00 million due to changes in accounting estimates for its Regenerative Medicine program. This adjustment came from “the now predicted use of preclinical human decedent testing,” which required updates to milestone technical criteria. Sales for the full year 2024 reached USD 440.10 million, dropping 10% from the previous year.

The situation became worse on May 12, 2025, with 3D Systems’ first quarter 2025 announcement. Revenue dropped to USD 94.50 million, an 8% decrease year-over-year that missed consensus estimates of USD 99.50 million. The company’s net loss grew to USD 37.00 million (USD 0.28 per share), more than double the USD 16.00 million loss from Q1 2024.

The adjusted loss reached USD 0.21 per share, exceeding analyst estimates of USD 0.14 per share. The adjusted EBITDA showed deeper losses at USD 23.90 million compared to USD 20.10 million in the first quarter of 2024.

The poor results stemmed from declining material sales, especially due to inventory problems in the Healthcare Solutions segment’s dental division. Healthcare Solutions saw revenue fall 9% to USD 41.30 million, while Industrial Solutions revenue decreased 7% to USD 53.20 million compared to last year.

The company’s decision to withdraw its full-year 2025 guidance due to “prolonged softness in customer capital spending and macroeconomic uncertainty” made things worse. This withdrawal combined with poor financial performance ended up causing a 26% stock price drop after the May announcement.

Legal hurdles under PSLRA challenge plaintiffs’ claims

The plaintiffs face major legal hurdles under the PSLRA, even with 3D Systems’ stock price falling after financial disclosures. This federal law sets tough standards that make it hard to prove securities fraud claims.

Plaintiffs must point out each misleading statement and explain exactly why it misled investors. They need to provide specific facts that support their claims. The PSLRA doesn’t allow allegations based on unnamed sources that could only be verified after discovery, especially when claims are made on “information and belief”.

Plaintiffs must prove six vital elements to avoid dismissal. These elements are material misrepresentation, scienter (intent to deceive), connection to securities transaction, reliance, economic loss, and loss causation. Proving scienter is nowhere near simple – plaintiffs must show each defendant either intended to deceive or acted with extreme recklessness.

3D Systems might argue that the market knew about industry challenges, even though sharp stock drops support the materiality claim. The company could say that reduced customer spending affected the whole industry rather than being a hidden company problem.

Plaintiffs must show how false statements directly led to their losses. This usually means proving that misrepresentations artificially inflated the stock price, which then fell when the truth came out. The stock price movements at the time of disclosures – March 27 (20.96% drop) and May 13, 2025 (26.6% drop) – will provide vital evidence.

Cases like this often end in settlements, which could limit how much money investors get back. Reports show 3D Systems paid investors about $50 million in a similar case in 2018, and this might set expectations for the current lawsuit.

Conclusion

The 3D Systems Class Action Lawsuit reveals a pattern of financial disclosures that led to dramatic drops in stock prices. The claims about investor deception raise serious questions about the company’s transparency and accountability. These allegations about downplayed negative effects and hidden partnership changes tell a troubling story for shareholders who lost money.

The stock price showed clear reactions – a 21% drop after March’s announcement and a 26.6% plunge after May’s poor results. Yet plaintiffs face major obstacles ahead. The PSLRA demands detailed proof of material misrepresentation, scienter, and direct loss causation. On top of that, 3D Systems could argue they properly disclosed industry-wide challenges in their SEC filings.

The company’s decision to withdraw its full-year 2025 outlook raises red flags about future performance. This shows management’s lack of confidence in current market conditions. Both current and potential investors need to carefully consider these legal and financial risks before making any moves.

Past cases might give us some clues about possible outcomes. A similar 2018 case ended in a $50 million settlement. In spite of that, each securities case comes with its own unique challenges. This ongoing lawsuit reminds us how crucial it is to do proper research and critically evaluate corporate disclosures in the unpredictable 3D printing industry.

Frequently Asked Questions about the 3D Systems Lawsuit

Q1. What is the main allegation in the 3D Systems class action lawsuit? The lawsuit alleges that 3D Systems and its executives made false and misleading statements about the company’s business conditions, understating negative impacts and overstating resilience during challenging times.

Q2. What triggered the significant stock price drops for 3D Systems? The stock price dropped nearly 21% after disappointing Q4 2024 results were announced in March 2025, and fell an additional 26.6% following poor Q1 2025 results and withdrawal of full-year guidance in May 2025.

Q3. What are the key legal challenges faced by the plaintiffs in this case? Plaintiffs must prove six critical elements under the Private Securities Litigation Reform Act, including material misrepresentation, scienter (intent to deceive), and loss causation, which are particularly difficult to establish in securities fraud cases.

Q4. How did 3D Systems’ financial performance contribute to the lawsuit? The company reported revenue declines, missed earnings estimates, and withdrew its full-year 2025 outlook, citing prolonged softness in customer spending and macroeconomic uncertainty, which raised concerns about the accuracy of previous statements.

Q5. What potential outcomes can be expected from this lawsuit? While outcomes vary, a previous similar case against 3D Systems in 2018 resulted in a settlement of approximately $50 million. However, the current case will be judged on its own merits, and settlements are common in such litigation.